Qbiotics, page-11

  1. 2,382 Posts.
    they could get upto $600-$800M for a successful trial drug phase1-2.........this represents about $2.00/share with the current share register at 387million. also we have the now approved vet drug happening, lets value this at the same , $2.00/share. MRK can take me over for $4.00/share, if you dont mind
 
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.